> > Rare diseases: to Aisla's 'promise,' neurologist Shneider: 'Italy is the capital...'

Rare diseases: to Aisla's 'promise,' neurologist Shneider calls Italy the capital of Tardbp research.

Rare diseases: to Aisla's 'promise,' neurologist Shneider calls Italy the capital of Tardbp research.

"Italy is the world capital of the Tardbp gene: there is an extraordinarily high number of people carrying variants or mutations in the gene. Consequently, our attention has quickly shifted to Italy." Great collaboration between "the Italian ALS community...

"Italy is the world capital of the Tardbp gene: there is an extraordinarily high number of people carrying variants or mutations in the gene. As a result, our attention has quickly shifted to Italy." There is great collaboration between "the Italian ALS community and, in the United States, between Italian-American doctors and researchers. Today," with ASO therapies, "we have opportunities that we could not have imagined just a few years ago: as I said before, ALS can be treated and controlled."

Thus Neil Shneider, Claire Tow Professor of Motor Neuron Disorders at Columbia University, and Director of the Eleanor and Lou Gehrig ALS Center at Columbia University (New York), in the interview given to Adnkronos Salute on the occasion of the event 'The Promise', promoted by Aisla – Italian Amyotrophic Lateral Sclerosis Association.

https://www.youtube.com/watch?v=gQngJjqSpho

Continue on the app The news of your city, in real time.
Open in app App Store